Form SC 13G Rapid Therapeutic Scienc Filed by: ARMISTICE CAPITAL, LLC
Filed on: February 14, 2024.
| Ticker |
RTSL
|
| CIK | 0001575659 |
| SIC | 2834 |
| Sector | Manufacturing |
| Industry Category | Pharmaceutical Products |
| Industry Group | Pharmaceutical Preparations |
| Address | 558 COUNTY ROAD 472, DE LEON, TX, 76444 |
| Website | rtslco.com |
| Phone | 800-497-6059 |
| CEO | N/A |
| Employees | 8 |
Our team will help you customize a package that meets the needs of your business.
Request a Consultation|
Standardized FinancialsdocsIntrinio provides professional-grade historical financial data. This data is standardized, cleansed and verified to ensure the highest quality data sourced directly from the XBRL financial statements. The primary purpose of standardized financials are to facilitate comparability across a single company’s fundamentals and across all companies fundamentals. For example, it is possible to compare total revenues between two companies as of a certain point in time, or within a single company across multiple time periods. This is not possible using the as reported financial statements because of the inherent complexity of reporting standards. Below is a preview of several data points from each financial statement, as well as a sample of our many calculated metrics: |
|||||||||||||||||||||
|
Income Statement
|
Balance Sheet
|
||||||||||||||||||||
|
Cash Flow Statement
|
Calculations
|
||||||||||||||||||||
|
Latest NewsdocsIntrinio provides up-to-date news articles on every US company from various sources. Here are several examples: |
Form SC 13G Rapid Therapeutic Scienc Filed by: ARMISTICE CAPITAL, LLCFiled on: February 14, 2024. Form SC 13G Rapid Therapeutic Scienc Filed by: ARMISTICE CAPITAL, LLCFiled on: February 14, 2024. White House Office of Management and Budget review on Cannabis-Derived Products confirms Rapid Therapeutic Science Laboratories’ Long-Term StrategyDALLAS, March 21, 2023 (GLOBE NEWSWIRE) -- Rapid Therapeutics Science Laboratories (OTC: RTSL) ("Rapid Therapeutic'' or the "Company"), a growth-oriented aerosol manufacturing company focused on natural relief innovations through trusted aerosol delivery, feels steadfast in strategic vision and directive following OMB clearance of the FDA’s Final Guidance On Clinical Research For Cannabis.On January 18th, 2023, The White House Office of Management and Budget completed its review of FDA’s final g |